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Abstract: 
 
Study Objective: Although underutilized, the vaginal contraceptive ring has several advantages 
over other contraceptive methods that could benefit adolescents. We examined factors that may 
influence willingness to try the vaginal ring including: sexual and contraceptive history, genital 
comfort, and vaginal ring characteristics. 
 
Design: Cross sectional 
 
Setting: Midwestern adolescent health clinics 
 
Participants: Adolescent women (N = 200; 14–18 years; 89% African-American) 
 
Interventions/Main Outcome Measures: All participants received education about the vaginal 
ring and viewed pictures demonstrating insertion; they then completed a visual/audio computer-
assisted self interview. The primary outcome variable, willingness to try the vaginal ring, was a 
single Likert-scale item. 
 
Results: Over half the participants reported knowledge of the vaginal ring with healthcare 
providers identified as the most important source of contraceptive information. Comfort with 
one’s genitals, insertion and removal, using alternative methods of insertion, and knowing 
positive method characteristics were significantly associated with willingness to try the vaginal 
ring. A decreased willingness to try the vaginal ring was related to concerns of the ring getting 
lost inside or falling out of the vagina. 
 
Conclusions: Willingness to try the ring was associated with positive feelings about genitals 
(e.g., comfort with appearance, hygiene, function). Thus, to increase willingness to try the 
vaginal ring among adolescents, providers should make it common practice to discuss basic 
female reproductive anatomy, raise awareness about female genital health and address concerns 
about their genitals. Providers can offer alternative insertion techniques (e.g., gloves) to make 
use more accessible. These strategies may increase vaginal ring use among adolescents. 
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Article: 
 
Introduction 
 
High rates of unintended adolescent pregnancy and birth are significant public health 
issues1, 2 underscoring the need for a variety of contraceptive options. Contraceptive methods 
that are not coitus-dependent, do not involve daily administration, and do not require injections 
could offer improved convenience and increased adherence. An option that may be more 
acceptable and used more successfully by adolescents is the vaginal contraceptive ring 
(NuvaRing, Organon USA, Roseland, NJ). The vaginal ring is a contraceptive method that is 
inserted once a month and is a combination of ethinyl estradiol (15 mcg/day) and etonogestrel 
(120 mcg/day) contained in a soft flexible 54 mm diameter silicone ring. Instructions recommend 
that the ring be placed in the vagina between days 1 and 5 of the menstrual cycle; it does not 
require placement in a specific location in the vagina—an advantage over the diaphragm. 
Vaginal rings are used continuously for three consecutive weeks and are then removed and 
discarded; ring removal allows for withdrawal bleeding during the subsequent seven days, after 
which a new ring is inserted.3 
 
The vaginal ring has several advantages over other contraceptive methods that may allow for 
more consistent and sustained use. It has been shown to be as effective as other combined 
hormonal methods, but with lower dose of estrogen leading to fewer side effects such as 
breakthrough bleeding, headache, and nausea.4 In contrast to the diaphragm, which requires 
specific vaginal insertion, skill in specific vaginal placement is not necessary with the vaginal 
ring. Additional benefits include monthly administration, easy self insertion and removal, option 
for continuous cycling, quick return to normal cycling after removal, low incidence of weight 
gain, and increased privacy and confidentiality because once the vaginal ring is placed it is not 
visible.5, 6, 7, 8, 9, 10, 11, 12 Currently under investigation is the use of the vaginal ring for delivery of 
topical microbicides for the prevention of sexually transmitted infections (STIs), including HIV. 
This would place an added benefit in favor of the vaginal ring as a single method that could be 
used for both pregnancy and disease prevention. In a comparison study, adult women used 
different methods of microbicide delivery; 52.9% of women had a preference for the vaginal ring 
over an applicator (36.4%) and diaphragm (10.7%).13 An advantage the ring has over the 
applicator and diaphragm is that insertion does not have to be timed with the sexual encounter, 
thus not affecting sexual spontaneity.13 
 
Vaginal ring acceptability studies have primarily been conducted with adult women (18 years 
and older). In large scale studies in North America and Europe, the vaginal ring has been 
established as a method of contraception with high compliance, safety, convenience, 
acceptability, comfort, and satisfaction.5, 7, 8, 9, 11, 14, 15 Recent work indicates that the vaginal ring 
is an acceptable contraceptive option for adolescent women with some barriers reported (e.g., 
method of insertion).15, 16, 17, 18, 19 However, it remains an underutilized form of hormonal 
contraception among adolescents since it was approved by the FDA in 2001. Reported vaginal 
ring use among adolescents has ranged from 0.6% to 6%,16, 20, 21 compared to 61% use of oral 
contraceptive pills and 20% use of the depot medroxyprogesterone (Depo-Provera).7, 22 
 
Accordingly, the purpose of this study was to identify factors that might facilitate the uptake and 
use of the vaginal ring more broadly by adolescent women. Specifically, we examined 
adolescent women’s willingness to try the vaginal ring after receiving standard educational 
information about the vaginal ring. Factors that may affect vaginal ring use and acceptability 
included: sexual and contraceptive history, genital comfort, and vaginal ring characteristics (e.g., 
method of insertion). 
 
Materials and Methods 
 
Participant Recruitment 
 
Between July 2009 and January 2010, 200 adolescent women were recruited to participate in a 
cross-sectional survey from five primary care adolescent medicine clinics in Indianapolis, 
Indiana. These clinics serve urban areas characterized by high rates of early unintended 
pregnancy and poverty. Inclusion criteria included female gender between 14 and 18 years old 
and English speaking. Study participants were eligible regardless of having or not having a 
medical indication for hormonal management of menses or prior history of sexual activity, 
because hormonal methods may be discussed with anticipation of future needs for contraception 
and for other reasons, such as menstrual problems. Previous use of a hormonal method, including 
previous vaginal ring use did not exclude participation. While understanding of vaginal ring 
acceptability among non-English speaking ethnic minorities is important, the majority of 
adolescent ethnic minorities speak English in the Indianapolis and Marion County area. 
 
Using an IRB-approved protocol (Indiana University and Purdue University at Indianapolis-
Clarian), young women were recruited weekly from the primary care clinics. Prior approval from 
the primary care physicians to approach their patients was obtained and potential study 
participants were approached in the exam room while waiting for their primary care physician. 
Before obtaining consent, the study was explained in detail, including procedure and duration. 
The study participants were informed that they could start the study while they waited for their 
primary care physician to enter the exam room and if they were unable to complete it in that 
time, they could complete it later. A waiver of parental permission was approved by the IRB for 
enrollment of participants because the study posed minimal risk and because the focus of the 
study was on contraceptive care. Under Indiana law, minors are not prohibited from seeking their 
own confidential health care pertaining to reproductive health care services. Overall, there were 
only five refusals; one refused to participate because she was not interested and four refused due 
to lack of time. 
 
Study Design and Procedures 
 
After informed consent was obtained, participants completed a one-time visual/audio computer-
assisted self interview (VA-CASI) on a laptop computer. The adolescent women answered by 
themselves questions they saw on the computer as well as heard through headphones. 
Advantages of computer-assisted data collection techniques over paper self-administered 
questionnaires include: improved validity of reports of sensitive behaviors, alleviated literacy 
issues with the audio component, greater protection of participant confidentiality because no 
written record exists, and decreased response errors and data entry errors for complex skip 
patterns.23, 24, 25 The questionnaire completion time ranged from 20–30 minutes and each 
participant received $20 as compensation for their time and effort. 
 
Study Measures 
 
The measures assessed demographics, sexual and contraception history, genital comfort, 
knowledge of the vaginal ring, and comfort with insertion and removal of the ring. Each 
participant received educational information about the vaginal ring on the computer which 
included mechanism of action, how it was used, common side effects, and benefits. Participants 
viewed pictures demonstrating insertion of the vaginal ring then were asked questions related to 
the importance of method characteristics as well as acceptability and willingness to try the 
vaginal ring. 
 
Demographics 
 
Using a multiple-choice format, we inquired about the participant’s age, race, ethnicity, 
education, sexual orientation, and relationship status. Participants also answered 21 multiple-
choice questions regarding their sexual behaviors, including: age at first sex, number of sexual 
partners, types of sexual behaviors (oral, vaginal, anal, and masturbation); pregnancy 
history including number of times being pregnant and number of deliveries; and contraceptive 
experience including: prior and current use of a variety of hormonal and non-hormonal methods. 
 
Vaginal Ring, Vaginal Product Use, Genital Comfort 
 
To assess knowledge of the vaginal ring, comfort with insertion and removal as well as genital 
comfort, a four-point Likert rating scaled was used (strongly disagree to strongly agree). 
Specifically, each study participant was asked if they had ever heard of the vaginal ring and who 
influenced their contraceptive choices using six items. Level of comfort with vaginal ring 
insertion and removal was assessed using two items, for example: “I feel comfortable with the 
idea of inserting (removing) the vaginal ring with my fingers.” Alternative methods of insertion 
were used to assess changes in level of comfort inserting the vaginal ring using the following two 
items, “I would be willing to try the vaginal ring if I could insert it with an applicator” and “I 
would be willing to try the vaginal ring if I could put a rubber glove on my hand before inserting 
it.” Experience with pelvic exams and vaginal product use (e.g., tampons, vaginal lubricants, 
douche, vaginal yeast infection medications) was assessed. In addition, a validated genital 
comfort scale26 was utilized to further assess the adolescent’s comfort in the appearance, hygiene 
and function of their genitals and included such items as: “I am not embarrassed about my 
genitals” and “I think my genitals work the way they are supposed to work.” To expand further 
on comfort with genital anatomy we included two items as: “I am worried the vaginal ring will 
get lost inside of me” and “I am worried the vaginal ring will fall out.” 
 
Method Characteristics 
 
To examine the influence of specific vaginal ring characteristics on willingness to try the vaginal 
ring, the adolescent women were asked about efficacy, side effects (e.g., weight gain), use, and 
privacy with seven items on a similar Likert rating scale such as: “I would use the vaginal ring 
because I only have to remember it once a month.” Although there is not a current dual method 
vaginal ring that protects against both pregnancy and sexually transmitted infections, it is under 
development.27 Thus, to assess the vaginal ring used as a dual method a single item (strongly 
disagree to strongly agree) was employed, “I would be willing to try the vaginal ring if it could 
also protect against sexually transmitted infections.” Finally, because intention to try a product 
has been correlated to health related behaviors,28 our outcome, vaginal ring acceptability, was 
measured with a single item: “I would be willing to try the vaginal ring.” 
 
Data Analysis 
 
Descriptive statistics were conducted to examine demographic variables. For most of the Likert 
scale measures the response categories were collapsed to create dichotomous response of 
agree/disagree. For the primary outcome of “I would be willing to try the vaginal ring,” the 
responses were not combined. Chi-square tests were used to assess relationships between 
attitudes toward willingness to use the vaginal ring and sexual and contraceptive history, genital 
comfort, vaginal ring insertion, and method characteristics. Data management and analysis were 
performed using SPSS 17.0. Statistically significant effects were considered at P < 0.05. 
 
Results 
 
Demographic and Behavioral Characteristics 
 
On average the adolescent women (N = 200) who completed the VA-CASI were 16.2 years (SD 
= 1.02); the majority identified as African-American (89.0%) and heterosexual (90.5%). Of the 
adolescent women, 67% had engaged in coitus with the mean age at first coitus 14.4 years (SD = 
1.47). Approximately 10% of the study participants had been pregnant at least once with at least 
one pregnancy resulting in a delivery. More than half of the study participants reported 
experience using tampons (57.0%) and vaginal yeast infection medications (54.5%). Only about 
one third (29.5%) of the study participants reported having had a speculum pelvic exam. The 
demographic and behavioral characteristics of study participants are shown in Table 1. 
 
Table 1. Study Participants’ Characteristics (N = 200) 
Demographics N (%)∗ 
Age (range 14–18 years), mean (SD) 16.2 (1.02) 
Race/ethnicity 
 
African American 178 (89.0) 
White 15 (7.5) 
Hispanic/Latina 2 (1.0) 
Other (Asian/Pacific Islander, American Indiana) 5 (3.5) 
Education 
 
Middle school (6th, 7th 8th ) 49 (24.5) 
High school (9th, 10th, 11th, 12th) 149 (74.5) 
Some college 2 (1.0) 
Demographics N (%)∗ 
Sexual preference 
 
Men 181 (90.5) 
Women 8 (4.0) 
Men and Women 11 (5.5) 
Relationship status 
 
One person for > 6 months 72 (36.0) 
One person for < 6 months 45 (22.5) 
More than 1 person 4 (2.0) 
Not dating or in relationship 79 (39.5) 
Vaginal product use (ever) 
 
Tampons 114 (57) 
Vaginal lubricants 20 (10) 
Douche 34 (17) 
Yeast infection medications 109 (54.5) 
Had pelvic exam with speculum 59 (29.5) 
Sexual history 
 
Age at first sex (in years), mean (SD) 14.4 (1.48) 
Never had sex 60 (30) 
Lifetime sexual partners 
 
1 42 (31.3) 
2 30 (22.4) 
3–5 42 (31.4) 
> 6 20 (14.9) 
Sexual behaviors (ever) 
 
Vaginal sex 134 (67) 
Anal sex 20 (10) 
Oral sex (giving) 49 (24.5) 
Oral sex (receiving) 87 (43.5) 
Masturbated 45 (22.5) 
Sexual behaviors (Last sex) 
 
Vaginal sex 115 (85.8) 
Anal sex 5 (2.5) 
Oral sex (giving) 24 (12.0) 
Oral sex (receiving) 56 (28.0) 
Ever pregnant 
 
Never 180 (90.0) 
Once 17 (8.5) 
Twice 2 (1.0) 
Three times 1 (0.5) 
Given birth 
 
Once 20 (10.0) 
Contraceptive history 
 
Never 54 (27.0) 
Depo provera 96 (48.0) 
Oral contraceptive pills 62 (31.0) 
Transdermal patch 35 (17.5) 
Vaginal ring 3 (1.5) 
Emergency contraception 5 (2.5) 
Male condoms 70 (35.0) 
Female condoms 3 (1.5) 
IUD 1 (0.5) 
Spermicides 4 (2.0) 
Avoid sex at certain times of month 16 (0.08) 
∗Except as otherwise indicated 
 
Contraceptive Behaviors and Knowledge 
 
More than two thirds (73.0%) of the study participants reported using some form of hormonal 
contraception; 27% of adolescent women had no experience with hormonal contraceptive. Close 
to half (48.0%) of the study participants had used Depo-Provera, , 31% oral contraceptive pills, 
17.5% the transdermal patch, and 1.5% the vaginal ring. Adolescents’ history of using male 
condoms was 35% while 1.5% reported using female condoms. 
 
About two thirds (66.0%) of the study participants stated they had heard of the vaginal ring. 
Adolescents learned about the vaginal ring from advertisements and TV (69.0%), their doctor 
(43.9%), a friend (22.0%), a family member (16.7%), or their partner (0.8%). In order of priority, 
participants indicated the strongest influences on their choice of a birth control method were their 
doctor (55.8%), family (52.3%), and friends or media (22.0%). 
 
Willingness to Try the Vaginal Ring 
 
When asked if they would be willing to try the vaginal ring, 6.5% of women strongly agreed and 
29.5% agreed. Conversely, a majority of the adolescents disagreed: 29.0% strongly disagreed 
and 35.0% disagreed that they would be willing to try the vaginal ring. 
 
Willingness to try the vaginal ring was associated with previous use of the contraceptive patch 
(P < 0.05). No other associations were detected between willingness to try and experience with 
other contraceptive methods. Contraceptive, sexual history, vaginal product use, and pelvic exam 
results are shown in Table 2. 
 
Table 2. Contraceptive, Sexual History, Vaginal Product Use and Pelvic Exam and its 
Association with Willingness to Try the Vaginal Ring (N = 200) 
Demographics χ2 (df) P value 
Vaginal Product Use (ever) 
  
Tampons 5.38 (3) 0.146 
Vaginal lubricants 2.31 (3) 0.511 
Douche 0.31 (3) 0.958 
Yeast infection medications 6.46 (6) 0.374 
Had pelvic exam with speculum 0.07 (3) 0.995 
Sexual History 
  
Age at first sex (in years), mean + SD 36.72 (27) 0.100 
Never had sex 1.89 (3) 0.594 
Lifetime sexual partners 17.75 (15) 0.276 
Sexual Behaviors (ever) 
  
Vaginal sex 1.74 (3) 0.629 
Anal sex 1.95 (3) 0.582 
Oral sex (giving) 2.72 (3) 0.437 
Oral sex (receiving) 1.05 (3) 0.789 
Masturbation 1.90 (3) 0.594 
Contraceptive History (ever) 
  
Never 5.12 (3) 0.163 
Depo provera 7.19 (3) 0.066 
Oral contraceptive pills 0.12 (3) 0.989 
Transdermal patch 8.65 (3) 0.034∗ 
Emergency contraception 3.58 (3) 0.310 
Demographics χ2 (df) P value 
Male condoms 1.45 (3) 0.695 
Female condoms 1.97 (3) 0.579 
IUD 2.40 (3) 0.493 
Spermicides 0.99 (3) 0.805 
*P < .05 
 
When examining associations between adolescent women willing and not willing to try to 
vaginal ring with genital comfort, vaginal ring insertion and removal, and method characteristics; 
several factors were statistically significant (see Table 3). For each measure, Table 3 highlights 
the differences among the four categories of willingness to try the vaginal ring—strongly agree, 
agree, disagree, and strongly disagree; the largest differences are seen between the agree and 
disagree categories. 
 
Table 3. Factors and Associations with Willingness to try the Vaginal Ring: Frequencies and 
Chi-square Test Results 
Willing to Try Vaginal Ring 
Measure Strongly 
Agree 
Agreed Disagreed Strongly 
Disagree 
Chi-Square 
χ2 (df) 
P value 
(N = 13) (N = 59) (N = 70) (N = 58) 
N (%) N (%) N (%) N (%) 
Genital Comfort Scale questions 
      
Think their genitals smell fine 13 (100.0) 56 (94.9) 66 (94.3) 53 (91.4) 18.45 (9) 0.030∗ 
Feel positive about their genitals 12 (92.3) 55 (93.2) 64 (91.4) 51 (87.9) 17.14 (9) 0.046∗ 
Satisfied with the appearance of my genitals 10 (76.9) 54 (91.5) 64 (91.4) 53 (91.4) 15.46 (9) 0.079 
Comfortable with sexual partner look at genitals 7 (53.8) 33 (55.9) 35 (50.0) 30 (51.7) 16.16 (9) 0.064 
Comfortable with provider examine genitals 10 (76.9) 41 (69.5) 48 (68.6) 40 (69.0) 20.38 (9) 0.016∗ 
Not embarrassed about my genitals 12 (92.3) 47 (79.7) 60 (85.7) 50 (86.2) 20.19 (9) 0.017∗ 
Belief genitals work like they should 13 (100.0) 57 (96.6) 67 (95.7) 57 (98.3) 15.94 (9) 0.068 
Extra Genital Comfort questions 
      
Worried it will get lost inside of me 6 (46.2) 35 (59.3) 56 (80.0) 43 (74.1) 50.59 (9) 0.000∗∗ 
Worried the ring will fall out 6 (46.2) 34 (57.6) 44 (62.9) 41 (70.7) 32.08 (9) 0.000∗∗ 
Vaginal Ring Insertion and Removal questions 
      
Comfortable inserting the ring with fingers 12 (92.3) 37 (62.7) 15 (21.4) 10 (17.2) 147.73 (9) 0.000∗∗ 
Comfortable removing the ring with fingers 9 (69.2) 37 (62.7) 12 (17.1) 9 (15.5) 114.93 (9) 0.000∗∗ 
Provider inserts ring the first time and I practice 
removing it in the clinic 
6 (46.1) 36 (61.0) 18 (25.7) 8 (13.8) 66.20 (9) 0.000∗∗ 
Insert it with an applicator 12 (92.3) 43 (72.9) 30 (42.9) 11 (19.0) 138.68 (9) 0.000∗∗ 
Insert it using a rubber glove 9 (69.2) 39 (66.1) 26 (37.1) 9 (15.5) 80.58 (9) 0.000∗∗ 
Method Characteristics questions 
      
Used only once a month 13 (100.0) 58 (98.3) 42 (60.0) 19 (32.8) 113.00 (9) 0.000∗∗ 
Effective in preventing pregnancy 13 (100.0) 57 (96.7) 51 (72.9) 21 (36.2) 95.73 (9) 0.000∗∗ 
Can control my periods 12 (92.3) 51 (86.4) 32 (45.7) 19 (32.8) 92.23 (9) 0.000∗∗ 
Lower amount side effects than other hormonal 
contraceptive methods 
13 (100.0) 56 (94.9) 40 (57.1) 19 (32.8) 127.02 (9) 0.000∗∗ 
Does not cause weight gain 13 (100.0) 51 (86.4) 44 (62.9) 21 (36.2) 84.50 (9) 0.000∗∗ 
Private and partner does not know I am using it 13 (100.0) 57 (96.6) 47 (67.1) 22 (37.9) 82.26 (9) 0.000∗∗ 
Should not feel it once it is inserted 13 (100.0) 56 (94.9) 43 (61.4) 18 (31.0) 123.02 (9) 0.000∗∗ 
What if it could protect against STIs 13 (100.0) 65 (94.9) 50 (71.4) 24 (41.4) 73.98 (9) 0.000∗∗ 
* P < 0.5 
** P < 0.001 
 
Although there was not a significant relationship between willingness to try the vaginal ring, and 
the overall genital comfort scale (F[15,184] = 1.21, P = 0.268), there were significant 
relationships with individual items in the scale. Willingness to try the vaginal ring was 
significantly associated with feeling positive about one’s genitals and thinking one’s genitals 
smelled fine. The preference for not feeling the ring once it is inserted and not being worried the 
ring would get lost inside of them were characteristics more likely to be reported by those who 
agreed they would be willing to try the vaginal ring compared to those who disagreed. Those 
who agreed they were willing to try the vaginal ring were more likely to report not being 
embarrassed about their genitals compared to those who disagreed, even though it was not 
statistically significant. Willingness to try the vaginal ring was also significantly associated with 
overall comfort with insertion and removal as well as using alternative methods of insertion such 
as using an applicator or a rubber glove. When comparing those adolescents who agreed to try 
the vaginal ring to those who disagreed, positive benefits and method characteristics of the 
vaginal ring (e.g., being used only once a month, lower amount of side effects than other 
hormonal contraceptives, and providing privacy), were significantly related to willingness to try. 
Additionally, there was varying levels of interest in a potential vaginal ring that could protect 
against pregnancy and sexually transmitted infections (in addition to its other benefits); see Table 
3. 
 
Discussion 
 
This study explored factors associated with willingness to try the vaginal ring among adolescent 
women aged 14–18 years. Recent work indicates that the vaginal ring is an acceptable 
contraceptive option for adolescent women;16, 17, 18, 29 our results align with current trends of the 
vaginal ring as an underutilized (and potentially underappreciated) form of contraception, as only 
3 (1.5%) adolescent women reported use.16, 18, 20, 21, 29 However, over one third of the adolescent 
women indicated that they were willing to try the vaginal ring after receiving educational 
materials and healthcare providers were identified as the most important source of information 
influencing contraceptive choices highlighting the important role of providers in contraceptive 
decision making for young women. 
 
Extant research describes genital comfort in the context of receiving multiple pelvic exams, 
using vaginal products, and frequent tampon use;16, 17, 19 our results did not detect an association 
between these factors and willingness to try the vaginal ring. Our findings suggest that genital 
comfort is more related to feeling positive about genitals—comfort with genital appearance, 
hygiene, and function. The ‘genital discomfort’ notion has been noted in some cross-cultural 
literature, with some women reporting they do not like to touch their genitals or insert products 
(e.g., tampons) vaginally.30 Our study findings confirm and extend this research that the main 
barrier to vaginal ring use and acceptability among adolescents is related to method of insertion 
and being comfortable with their genitals.17, 20, 29 In order to use the vaginal ring, adolescent 
women need to become comfortable with their genitals, thus highlighting the importance of 
education and practice in clinical and nonclinical settings. 
 
It is reported that adolescent women who had used the vaginal ring had concerns about insertion 
method, cleanliness, and touching the vagina.16, 17, 20 Our study uniquely explored these ideas by 
offering alternative insertion techniques, such as inserting the vaginal ring with a tampon 
applicator, instructions to insert the vaginal ring while wearing a rubber glove, or having the 
healthcare provider insert the vaginal ring for the adolescent women in the office the first time 
and have them practice removing it before they leave. All of these alternative insertion 
techniques resulted in higher percentages of willingness to try the vaginal ring among the 
adolescents. 
 
Fear of pain, injury, not being able to remove the item, losing it inside the body, or introducing 
an infection to the vagina have been cited as additional reasons for reluctance to use the vaginal 
ring.30 Similarly, our results suggested a decreased willingness to try the vaginal ring related to 
concerns the ring getting lost inside the vagina or falling out. Healthcare providers may need to 
focus their discussions on basic female reproductive anatomy and specifically address why the 
ring will not travel up through their body and how the vaginal muscles keep the vaginal ring in 
place. 
 
Previous research associated vaginal ring acceptability with older age which was hypothesized to 
be related to increased sexual experiences;16 our results did not detect associations between age, 
sexual experiences, and willingness to try the vaginal ring. However, similar to other work,29 we 
did detect an association in willingness to try to the vaginal ring with contraceptive patch use, 
which may be related to adolescent women preferring alternative and more convenient 
contraceptive methods over oral contraceptive pills. Our study found no relationships with any 
other sexual health variables. For these young women willingness to try the vaginal ring was 
related to genital comfort, method of insertion, and information regarding the positive benefits 
and method characteristics. 
 
The practice of vaginal douching and use of tampons for menstrual hygiene are common 
practices among adolescent women31 suggesting that many adolescent women have overcome 
negative feelings about touching their genitals or inserting products vaginally.30 An area of active 
research involves the use of intravaginal rings—similar to those described above—for delivery 
of topical antimicrobial drugs for the prevention of STIs, including HIV.32, 33, 34 This would place 
an added benefit in favor of the vaginal ring as a single method that could be used for both 
pregnancy and disease prevention; many of the adolescent women reported a preference for this 
option. More than half of those who were unwilling to try the vaginal ring and more than 95% of 
those who were willing to try the ring reported they would try the ring if it could protect against 
STIs. 
 
The use of VA-CASI allowed collection of data as well as the delivery of educational 
information about the ring comparable to the information and counseling a patient would receive 
from a provider. However, the participants were not given a chance to ask questions for either 
clarification or further information. In addition, due to the nature of the clinics in which these 
women were recruited, incidence of sexual intercourse as well as experiences with pregnancies 
and birth might be greater than in the general population; for this reason, their preferences may 
not be reflective of the larger population. Although willingness to try a product has been used as 
a proxy measure for behaviors, it is unclear if this willingness to try contraceptives leads to 
behavioral action.28 Finally, while the vaginal ring is covered in our state by Medicaid, this may 
not be true for other states. One barrier to access of the vaginal contraceptive ring is cost and the 
vaginal ring not being available in generic form, resulting in high co-pays or self pay.16, 35 The 
cost may prevent an adolescent from using it even if it is their preferred method of contraception. 
If the vaginal ring becomes available as a generic, this barrier will be reduced. 
 
In summary, this study provides new information on the association between willingness to try 
the vaginal ring and genital comfort, method of insertion, and method characteristics. To help 
improve acceptability to adolescents about this effective, convenient, nondaily hormonal 
contraceptive method as well as increase the adolescent patients’ willingness to try the vaginal 
ring, healthcare providers should focus on offering alternative insertion techniques such as 
having their patient try inserting it with a tampon applicator, instructing them to insert the 
vaginal ring while wearing a rubber glove, as well as having the patients insert and remove the 
ring during the office visit. Healthcare providers may also help improve acceptability of this 
contraceptive method by making it common practice to raise awareness with their adolescent 
patients about their genitals and addressing any anatomical or contraceptive concerns. Assisting 
adolescent women with their contraceptive choice is essential for improving the adolescents 
understanding and motivation of specific contraceptive options, reducing unintended 
pregnancies, and promoting sexual and reproductive health. 
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